VCAM1 and astrocytoma (excluding glioblastoma): One of the principle observations resulting from these studies is that cytokine treatment of primary low-passage glioma cell lines induces the expression of VCAM-1, expanding the previously observed cytokine induction of VCAM-1 on astrocytoma cell lines [24], as well as on other transformed and non-transformed cell types [25], [26].